REGISTERED NUMBER: 08751322 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2026

for

MEDICALS PLUS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr D Wong

Mrs C Wong

REGISTERED OFFICE:

Kensington House

3 Kensington

Bishop Auckland

Co. Durham

DL14 6HX

REGISTERED NUMBER:

08751322 (England and Wales)

ACCOUNTANTS:

Mitchells Grievson

Chartered Accountants

Kensington House

3 Kensington

Bishop Auckland

Co. Durham

DL14 6HX

FIXED ASSETS

Tangible assets

4

82,614

113,995

Investments

5

277,956

197,242

360,570

311,237

CURRENT ASSETS

Debtors

6

136,180

106,162

Cash at bank

122,184

70,703

258,364

176,865

CREDITORS

Amounts falling due within one year

7

126,559

55,241

NET CURRENT ASSETS

131,805

121,624

TOTAL ASSETS LESS CURRENT LIABILITIES

492,375

432,861

CREDITORS

Amounts falling due after more than one year

8

(85,947

)

(102,415

)

PROVISIONS FOR LIABILITIES

(20,654

)

(28,499

)

NET ASSETS

385,774

301,947

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

385,772

301,945

385,774

301,947

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2026 and were signed on its behalf by:

Dr D Wong - Director

Mrs C Wong - Director

1.	STATUTORY INFORMATION

Medicals Plus Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

15% on reducing balance

Motor vehicles

-

20% on reducing balance

Computer equipment

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2025 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

£

£

£

COST

At 1 April 2025

26,651

88,090

69,905

184,646

Additions

350

-

-

350

Disposals

-

-

(26,863

)

(26,863

)

At 31 March 2026

27,001

88,090

43,042

158,133

DEPRECIATION

At 1 April 2025

16,431

6,222

47,998

70,651

Charge for year

1,585

16,374

13,302

31,261

Eliminated on disposal

-

-

(26,393

)

(26,393

)

At 31 March 2026

18,016

22,596

34,907

75,519

NET BOOK VALUE

At 31 March 2026

8,985

65,494

8,135

82,614

At 31 March 2025

10,220

81,868

21,907

113,995

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1 April 2025

197,242

Additions

60,700

Revaluations

20,014

At 31 March 2026

277,956

NET BOOK VALUE

At 31 March 2026

277,956

At 31 March 2025

197,242

Cost or valuation at 31 March 2026 is represented by:

Other

investments

£

Valuation in 2021

3,163

Valuation in 2022

(3,794

)

Valuation in 2023

(12,697

)

Valuation in 2024

15,624

Valuation in 2025

13,039

Valuation in 2026

20,014

Cost

242,607

277,956

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

114,815

84,465

Other debtors

21,365

21,697

136,180

106,162

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Bank loans and overdrafts

5,605

5,467

Hire purchase contracts

10,864

7,652

Trade creditors

6,754

6,200

Taxation and social security

59,604

27,118

Other creditors

43,732

8,804

126,559

55,241

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2026

2025

£

£

Bank loans

21,661

27,265

Hire purchase contracts

64,286

75,150

85,947

102,415

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

-

3,980

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

2026

2025

£

£

Dr D Wong

Balance outstanding at start of year

9,240

9,104

Amounts advanced

35,342

26,536

Amounts repaid

(35,379

)

(26,400

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

9,203

9,240

Mrs C Wong

Balance outstanding at start of year

9,452

9,196

Amounts advanced

50,961

47,256

Amounts repaid

(50,857

)

(47,000

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

9,556

9,452